Multiple mutations and increased RNA expression in tetracycline-resistant Streptococcus pneumoniae as determined by genome-wide DNA and mRNA sequencing

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 7, 2015, Pages 1946-1959

  Lupien, Andréanne ^a   Gingras, Hélène ^a   Bergeron, Michel G ^a   Leprohon, Philippe ^a   Ouellette, Marc ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

ABC transporters; Genomic; RNA seq; RpsJ; S. pneumoniae; Thiamine

Indexed keywords

ABC TRANSPORTER; CIPROFLOXACIN; DNA; ETHIDIUM BROMIDE; MESSENGER RNA; TETRACYCLINE; THIAMINE; TRANSCRIPTOME;

ANTIBIOTIC RESISTANCE; ARTICLE; DNA SEQUENCE; GENE EXPRESSION; GENE MUTATION; GENE ONTOLOGY; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC TRANSFORMATION; NEXT GENERATION SEQUENCING; NONHUMAN; PHENOTYPE; PROMOTER REGION; RNA SEQUENCE; STREPTOCOCCUS PNEUMONIAE; TETRACYCLINE RESISTANT STREPTOCOCCUS PNEUMONIAE;

EID: 84936952689     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv060     Document Type: Article

References (67)

1. Levine OS, O'Brien KL, Knoll M et al. Pneumococcal vaccination in developing countries. Lancet 2006; 367: 1880-2.
2. McGee L, McDougal L, Zhou J et al. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J Clin Microbiol 2001; 39: 2565-71.
3. Hansman D. BMM. A resistant pneumococcus. Lancet 1967; 290: 264-5.
4. Parra EL, Ramos V, Sanabria O et al. Serotype and genotype distribution among invasive Streptococcus pneumoniae isolates in Colombia, 2005-2010. PLoS One 2014; 9: e84993.
5. Zhou L, Ma X, Gao W et al. Molecular characteristics of erythromycinresistant Streptococcus pneumoniae from pediatric patients younger than five years in Beijing, 2010. BMC Microbiol 2012; 12: 228.
6. Montanari MP, Cochetti I, Mingoia M et al. Phenotypic and molecular characterization of tetracycline-and erythromycin-resistant strains of Streptococcus pneumoniae. Antimicrob Agents Chemother 2003; 47: 2236-41.
7. Sa-Leao R, Tomasz A, Sanches IS et al. Carriage of internationally spread clones of Streptococcus pneumoniae with unusual drug resistance patterns in children attending day care centers in Lisbon, Portugal. J Infect Dis 2000; 182: 1153-60.
8. Jones RN, Sader HS, Moet GJ et al. Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: report from the SENTRY Antimicrobial Surveillance Program (1998-2009). Diagn Microbiol Infect Dis 2010; 68: 334-6.
9. Wyres KL, van Tonder A, Lambertsen LM et al. Evidence of antimicrobial resistance-conferring genetic elements among pneumococci isolated prior to 1974. BMC Genomics 2013; 14: 500.
10. Kim SH, Song JH, Chung DR et al. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob Agents Chemother 2012; 56: 1418-26.
11. Johnson JR. Doxycycline for treatment of community-acquired pneumonia. Clin Infect Dis 2002; 35: 632; author reply-3.
12. Izdebski R, Sadowy E, Fiett J et al. Clonal diversity and resistance mechanisms in tetracycline-nonsusceptible Streptococcus pneumoniae isolates in Poland. Antimicrob Agents Chemother 2007; 51: 1155-63.
13. Lederman ER, Gleeson TD, Driscoll T et al. Doxycycline sensitivity of S. pneumoniae isolates. Clin Infect Dis 2003; 36: 1091.
14. Connell SR, Tracz DM, Nierhaus KH et al. Ribosomal protection proteins and their mechanism of tetracycline resistance. Antimicrob Agents Chemother 2003; 47: 3675-81.
15. Yang W, Moore IF, Koteva KP et al. TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics. J Biol Chem 2004; 279: 52346-52.
16. Nguyen F, Starosta AL, Arenz S et al. Tetracycline antibiotics and resistance mechanisms. Biol Chem 2014; 395: 559-75.
17. Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 2001; 65: 232-60; second page, table of contents.
18. Doherty N, Trzcinski K, Pickerill P et al. Genetic diversity of the tet(M) gene in tetracycline-resistant clonal lineages of Streptococcus pneumoniae. Antimicrob Agents Chemother 2000; 44: 2979-84.
19. Widdowson CA, Klugman KP. The molecular mechanisms of tetracycline resistance in the pneumococcus. Microb Drug Resist 1998; 4: 79-84.
20. Widdowson CA, Klugman KP, Hanslo D. Identification of the tetracycline resistance gene, tet(O), in Streptococcus pneumoniae. Antimicrob Agents Chemother 1996; 40: 2891-3.
21. Donhofer A, Franckenberg S, Wickles S et al. Structural basis for TetM-mediated tetracycline resistance. Proc Natl Acad Sci USA 2012; 109: 16900-5.
22. Wu JY, Kim JJ, Reddy R et al. Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes. Antimicrob Agents Chemother 2005; 49: 578-83.
23. Dailidiene D, Bertoli MT, Miciuleviciene J et al. Emergence of tetracycline resistance in Helicobacter pylori: multiple mutational changes in 16S ribosomal DNA and other genetic loci. Antimicrob Agents Chemother 2002; 46: 3940-6.
24. Hu M, Nandi S, Davies C et al. High-level chromosomally mediated tetracycline resistance in Neisseria gonorrhoeae results from a point mutation in the rpsJ gene encoding ribosomal protein S10 in combination with the mtrR and penB resistance determinants. Antimicrob Agents Chemother 2005; 49: 4327-34.
25. Huda N, Lee EW, Chen J et al. Molecular cloning and characterization of an ABC multidrug efflux pump, VcaM, in Non-O1 Vibrio cholerae. Antimicrob Agents Chemother 2003; 47: 2413-7.
26. Al-Hamad A, Upton M, Burnie J. Molecular cloning and characterization of SmrA, a novel ABC multidrug efflux pump from Stenotrophomonas maltophilia. J Antimicrob Chemother 2009; 64: 731-4.
27. Matsuo T, Chen J, Minato Y et al. SmdAB, a heterodimeric ABC-Type multidrug efflux pump, in Serratia marcescens. J Bacteriol 2008; 190: 648-54.
28. Avrain L, Garvey M, Mesaros N et al. Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations. J Antimicrob Chemother 2007; 60: 965-72.
29. Garvey MI, Piddock LJ. The efflux pump inhibitor reserpine selects multidrug-resistant Streptococcus pneumoniae strains that overexpress the ABC transporters PatA and PatB. Antimicrob Agents Chemother 2008; 52: 1677-85.
30. El Garch F, Lismond A, Piddock LJ et al. Fluoroquinolones induce the expression of patA and patB, which encode ABC efflux pumps in Streptococcus pneumoniae. J Antimicrob Chemother 2010; 65: 2076-82.
31. Garvey MI, Baylay AJ, Wong RL et al. Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 2011; 55: 190-6.
32. Lupien A, Billal DS, Fani F et al. Genomic characterization of ciprofloxacin resistance in a laboratory-derived mutant and a clinical isolate of Streptococcus pneumoniae. Antimicrob Agents Chemother 2013; 57: 4911-9.
33. Fani F, Brotherton MC, Leprohon P et al. Genomic analysis and reconstruction of cefotaxime resistance in Streptococcus pneumoniae. J Antimicrob Chemother 2013; 68: 1718-27.
34. Fani F, Leprohon P, Legare D et al. Whole genome sequencing of penicillin-resistant Streptococcus pneumoniae reveals mutations in penicillin-binding proteins and in a putative iron permease. Genome Biol 2011; 12: R115.
35. Feng J, Lupien A, Gingras H et al. Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance. Genome Res 2009; 19: 1214-23.
36. Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 2014; 30: 2114-20.
37. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754-60.
38. Li H, Handsaker B, Wysoker A et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009; 25: 2078-9.
39. Billal DS, Feng J, Leprohon P et al. Whole genome analysis of linezolid resistance in Streptococcus pneumoniae reveals resistance and compensatory mutations. BMC Genomics 2011; 12: 512.
40. Trapnell C, Roberts A, Goff L et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 2012; 7: 562-78.
41. Conesa A, Gotz S, Garcia-Gomez JM et al. Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research. Bioinformatics 2005; 21: 3674-6.
42. McMurry L, Levy SB. Two transport systems for tetracycline in sensitive Escherichia coli: critical role for an initial rapid uptake system insensitive to energy inhibitors. Antimicrob Agents Chemother 1978; 14: 201-9.
43. Dallas SD, McGee L, Limbago B et al. Development of doxycycline MIC and disk diffusion interpretive breakpoints and revision of tetracycline breakpoints for Streptococcus pneumoniae. J Clin Microbiol 2013; 51: 1798-802.
44. Boncoeur E, Durmort C, Bernay B et al. PatA and PatB form a functional heterodimeric ABC multidrug efflux transporter responsible for the resistance of Streptococcus pneumoniae to fluoroquinolones. Biochemistry 2012; 51: 7755-65.
45. Croucher NJ, Mitchell AM, Gould KA et al. Dominant role of nucleotide substitution in the diversification of serotype 3 pneumococci over decades and during a single infection. PLoS Genet 2013; 9: e1003868.
46. Schmitz FJ, Fluit AC, Luckefahr M et al. The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 1998; 42: 807-10.
47. Jung IL, Kim IG. Thiamine protects against paraquat-induced damage: scavenging activity of reactive oxygen species. Environ Toxicol Pharmacol 2003; 15: 19-26.
48. Fukui K, Wakamatsu T, Agari Y et al. Inactivation of the DNA repair genes mutS, mutL or the anti-recombination gene mutS2 leads to activation of vitamin B1 biosynthesis genes. PLoS One 2011; 6: e19053.
49. Tunc-Ozdemir M, Miller G, Song L et al. Thiamin confers enhanced tolerance to oxidative stress in Arabidopsis. Plant Physiol 2009; 151: 421-32.
50. Rapala-Kozik M, Wolak N, Kujda M et al. The upregulation of thiamine (vitamin B1) biosynthesis in Arabidopsis thaliana seedlings under salt and osmotic stress conditions is mediated by abscisic acid at the early stages of this stress response. BMC Plant Biol 2012; 12: 2.
51. Kowalska E, Kujda M, Wolak N et al. Altered expression and activities of enzymes involved in thiamine diphosphate biosynthesis in Saccharomyces cerevisiae under oxidative and osmotic stress. FEMS Yeast Res 2012; 12: 534-46.
52. Lakaye B, Wirtzfeld B, Wins P et al. Thiamine triphosphate, a new signal required for optimal growth of Escherichia coli during amino acid starvation. J Biol Chem 2004; 279: 17142-7.
53. Brodersen DE, Clemons WM Jr, Carter AP et al. The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell 2000; 103: 1143-54.
54. Robertson GT, Doyle TB, Lynch AS. Use of an efflux-deficient Streptococcus pneumoniae strain panel to identify ABC-class multidrug transporters involved in intrinsic resistance to antimicrobial agents. Antimicrob Agents Chemother 2005; 49: 4781-3.
55. Tocci N, Iannelli F, Bidossi A et al. Functional analysis of pneumococcal drug efflux pumps associates the MATE DinF transporter with quinolone susceptibility. Antimicrob Agents Chemother 2013; 57: 248-53.
56. Fernandez-Moreno MA, Carbo L, Cuesta T et al. A silent ABC transporter isolated from Streptomyces rochei F20 induces multidrug resistance. J Bacteriol 1998; 180: 4017-23.
57. Baylay AJ, Piddock LJV. Clinically relevant fluoroquinolone resistance due to constitutive overexpression of the PatAB ABC transporter in Streptococcus pneumoniae is conferred by disruption of a transcriptional attenuator. J Antimicrob Chemother 2015; 70: 670-9.
58. Abreu-Goodger C, Merino E. RibEx: a web server for locating riboswitches and other conserved bacterial regulatory elements. Nucleic Acids Res 2005; 33: W690-2.
59. Grohs P, Trieu-Cuot P, Podglajen I et al. Molecular basis for different levels of tet(M) expression in Streptococcus pneumoniae clinical isolates. Antimicrob Agents Chemother 2012; 56: 5040-5.
60. Dawson RJ, Locher KP. Structure of a bacterial multidrug ABC transporter. Nature 2006; 443: 180-5.
61. Loo TW, Clarke DM. Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux. J Membr Biol 2005; 206: 173-85.
62. Higgins CF, Linton KJ. The ATP switch model for ABC transporters. Nat Struct Mol Biol 2004; 11: 918-26.
63. Higgins CF. Multiple molecular mechanisms for multidrug resistance transporters. Nature 2007; 446: 749-57.
64. Bohnert JA, Schuster S, Fahnrich E et al. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF). J Antimicrob Chemother 2007; 59: 1216-22.
65. Vettoretti L, Plesiat P, Muller C et al. Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 2009; 53: 1987-97.
66. Du Q, Wang H, Xie J. Thiamin (vitamin B1) biosynthesis and regulation: a rich source of antimicrobial drug targets? Int J Biol Sci 2011; 7: 41-52.
67. Bettendorff L, Wirtzfeld B, Makarchikov AF et al. Discovery of a natural thiamine adenine nucleotide. Nat Chem Biol 2007; 3: 211-2.